Home / Stocks / Tatva Chin Pharm Chem Ltd
TATVA

Tatva Chin Pharm Chem Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹1,637.2

Change

-11.7 (-0.71%)

Open

₹1,648.9

Prev. Close

₹1,648.9

Day High

₹1,652.7

Day Low

₹1,623.0

Volume Analysis

Traded

16,481

Delivered

8,404

Delivery %

50.99%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (2)

  • •Low return on equity (5.54%)
  • •Below-average fundamentals quality score (47/100)

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹1,681.96 ₹1,667.33 ₹1,652.26 ₹1,637.63 ₹1,622.56 ₹1,607.93 ₹1,592.86
Fibonacci ₹1,667.33 ₹1,655.98 ₹1,648.98 ₹1,637.63 ₹1,626.28 ₹1,619.28 ₹1,607.93
Camarilla ₹1,645.37 ₹1,642.65 ₹1,639.92 ₹1,637.63 ₹1,634.48 ₹1,631.76 ₹1,629.03

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+23.59%

1 Week

-1.37%

1 Month

-13.38%

3 Months

+1.29%

6 Months

+37.87%

1 Year

+6.86%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹375.21

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

5.97%

Net margin 9.69% × asset turnover 0.45x × equity multiplier 1.37x

Company Overview

Sector

Chemicals

Market Cap

₹3,937 Cr

P/E (TTM)

61.6

ROE

5.54%

Book Value

₹348.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 15 Nov 2026. Not investment advice.

TopFund Analysis

Tatva Chin Pharm Chem Ltd scores weakly on TopFund's composite fundamentals check within the Chemicals sector, at 47/100. The strongest factor is Financial Strength (100/100), while Cash Flow (11/100) is the weakest area to weigh before deciding. Notably: Low return on equity (5.54%); below-average fundamentals quality score (47/100).

TopFund Score — Fundamentals Quality

47/100 — Weak

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

21

Valuation

20

Cash Flow

11

Corporate Governance

75

Momentum

60

Institutional Ownership

26

Business Quality

55

Risk & Volatility

43

Liquidity

36

From Screener.in

  • +Company is expected to give good quarter
  • +Company has been maintaining a healthy dividend payout of 22.5%
  • +Company's working capital requirements have reduced from 133 days to 92.0 days
  • −Stock is trading at 4.83 times its book value
  • −The company has delivered a poor sales growth of 11.0% over past five years.
  • −Company has a low return on equity of 3.68% over last 3 years.
  • −Company might be capitalizing the interest cost

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Newspaper Publication of Extract of Financial Results of the Company for the quarter and half year ended 30 September 2026.

Investor Presentation for the quarter and half year ended 30 September 2026.

Tatva Chintan cancelled its 19 October 2026 earnings call due to unforeseen circumstances.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 97 84 98 105 83 86 108 117 124 131 134 167 217
Expenses + 76 73 83 93 78 79 99 100 101 106 106 135 177
Operating Profit 20 11 16 13 6 7 9 17 22 25 28 32 41
OPM % 21.0% 13.0% 16.0% 12.0% 7.0% 8.0% 8.0% 15.0% 18.0% 19.0% 21.0% 19.0% 19.0%
Other Income + 1 1 5 1 0 0 1 1 1 2 0 1 2
Interest 3 0 0 0 0 0 0 0 1 0 1 2 3
Depreciation 7 7 6 7 7 7 7 9 9 9 10 11 11
Profit before tax 11 5 14 7 -1 0 2 9 14 18 17 21 29
Tax % 31.0% 34.0% 30.0% 24.0% -34.0% -165.0% 49.0% 27.0% 27.0% 14.0% 38.0% 24.0% 26.0%
Net Profit + 8 3 10 5 -1 0 1 7 10 15 10 16 21
EPS in Rs 3 1 4 2 0 0 0 3 4 6 4 7 9
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 7 -30 -21 -8 -14 2 10 11 48 53 24 43 76

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 136 206 263 300 434 424 394 383 506 650
Expenses + 113 172 208 234 325 363 325 348 412 523
Operating Profit 23 34 55 67 109 61 69 35 94 127
OPM % 17.0% 17.0% 21.0% 22.0% 25.0% 14.0% 17.0% 9.0% 18.0% 19.0%
Other Income + 1 1 1 5 9 2 7 2 3 5
Interest 3 4 4 4 5 9 7 2 3 7
Depreciation 3 4 5 7 8 10 26 28 37 40
Profit before tax 19 27 48 61 104 45 44 8 57 84
Tax % 35.0% 25.0% 21.0% 14.0% 8.0% -2.0% 30.0% 25.0% 26.0% —
Net Profit + 12 21 38 52 96 45 30 6 42 63
EPS in Rs 6 10 19 26 43 21 13 2 18 27
Dividend Payout % 0.0% 0.0% 0.0% 19.0% 5.0% 10.0% 15.0% 41.0% 11.0% —
Sales growth — 52 28 14 44 -2 -7 -3 32 50

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 51 72 110 146 451 493 714 715 758 791
Borrowings + 56 77 91 90 120 170 14 36 120 170
Other Liabilities + 28 31 41 59 65 74 67 61 102 134
Total Liabilities 144 188 249 315 658 759 819 836 1,004 1,119
Fixed Assets + 57 67 111 120 160 196 427 529 609 595
CWIP 10 6 5 10 51 231 77 24 25 43
Investments 1 0 0 0 0 0 10 0 4 4
Other Assets + 76 115 133 185 447 332 305 283 365 477
Total Assets 144 188 249 315 658 759 819 836 1,004 1,119
Equity Capital 8 8 8 20 22 22 23 23 23 23

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 13 7 25 20 20 28 98 25 31
Cash from Investing Activity + -30 -17 -40 -21 -197 -101 -121 -65 -116
Cash from Financing Activity + 7 17 10 -5 235 38 31 17 79
Net Cash Flow -10 8 -5 -6 59 -36 8 -24 -6
Free Cash Flow -18 -2 -23 -1 -69 -175 -30 -51 -82
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 105 39 61 44 36 61 157 85 42

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 72.02% → 72.02%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 10.72% 11.49% 13.97% 17.81% 18.27% 19.21% 19.6% 20.72% 20.49% 21.16% 20.94% 20.39%
Promoters 72.02% 72.02% 72.02% 72.02% 72.02% 72.02% 72.02% 72.02% 72.02% 72.02% 72.02% 72.02%
FII 4.21% 3.65% 3.37% 3.33% 3.36% 3.3% 3.26% 3.4% 4.17% 3.81% 3.93% 4.38%
DII 13.06% 12.84% 10.64% 6.83% 6.34% 5.46% 5.11% 3.87% 3.32% 2.99% 3.11% 3.21%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Chemicals — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Tatva Chin Pharm Chem Ltd (this stock) 3,937 61.6 4.84 5.54%
Chemplast Sanmar Limited 3,888 — 2.46 -6.8%
Dhanuka Agritech Ltd 4,010 13.3 2.28 20.5%
Epigral Limited 4,094 14.4 1.73 16.0%
Vishnu Chemicals Limited 3,700 24.3 3.24 14.3%
Steamhouse India Limited 4,178 96.0 7.22 25.3%
Rallis India Ltd 3,684 23.3 2.17 9.61%

Which Mutual Funds Hold Tatva Chin Pharm Chem Ltd?

Frequently Asked Questions about Tatva Chin Pharm Chem Ltd

Community Sentiment

What are other investors saying about Tatva Chin Pharm Chem Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.